Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4 small nuclear 49, pseudogene (RNU4-49P) is a pseudogene of the U4 small nuclear RNA (snRNA) gene family[5]. U4 snRNA plays a role as a non-coding component of the major spliceosome complex, essential for pre-mRNA splicing in eukaryotes[1]. However, RNU4-49P itself is classified as a pseudogene, meaning it is a non-functional genomic copy that does not produce a functional RNA or protein product[5]. There is no evidence that RNU4-49P is involved in disease, encodes a protein, acts as a drug target, or participates in biological functions or signaling pathways. It therefore is not considered a therapeutic target. Pseudogenes, such as RNU4-49P, commonly arise from the reverse transcription and reintegration of RNA genes, leading to sequences similar to the parental gene but typically lacking regulatory elements or accumulating mutations that render them non-functional[3]. The major, functional copies of U4 snRNA—such as those encoded by *RNU4-1* and *RNU4-2*—are implicated in disease only when mutated, but these effects do not extend to snRNA pseudogenes like RNU4-49P[2][6][7]. The pseudogene itself is not linked to disorder or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 49, pseudogene (RNU4-49P).